Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sridharan Gururangan
Pediatric Brain Tumor Consortium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Lurie Children'S Hospital-Chicago
Chicago, Illinois, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Children'S Hospital of Pittsburgh of Upmc
Pittsburgh, Pennsylvania, United States
- Pediatric Brain Tumor Consortium
Memphis, Tennessee, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Texas Children'S Hospital
Houston, Texas, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2006
- Primary completion
- 31 Oct 2015
- Completion
- 31 Oct 2015
- Last update posted
- 28 Nov 2017
- Registered enrollment
- 97
- Registry id
- NCT00381797
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.